SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma

Overview of attention for article published in Frontiers in oncology, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,682 followers.

🔥 Hottest @FrontOncology articles this week #5: SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma 👩‍⚕️👨‍⚕️ Oriane Lié, Thierry Virolle et al. Read now 👉 https://t.co/jXVjiHSmSh @UnivTours @Univ_CotedAzur @Inserm #Glioblastoma #BrainCance

07 Jan 2022

Reply Repost Favourite

RT @FrontOncology: New research: SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma: Recent evidence suggests that the chimeri…

04 Jan 2022

Reply Repost Favourite

New research: SETMAR Shorter Isoform: A New Prognostic Factor in Glioblastoma: Recent evidence suggests that the chimeric protein SETMAR is a factor of interest in cancer, especially in glioblastoma. However, little is known about the… https://t.co/Ix9cP8j

04 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.